$TWST
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
Healthcare
Sector
Medical - Diagnostics & Research
Industry
Emily Marine Leproust
CEO
923
Employees
$151.42
Current Price
$3.22B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 6 | 7 | $2,383,797.42 | 17,131 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 6 | 15 | $13,444,502.76 | 109,691 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 8 | 25 | $34,883,415.38 | 288,182 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 8 | 27 | $35,319,855.18 | 292,819 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 8 | 39 | $41,067,928.78 | 359,276 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 29, 2026 | Laponis Adam Chief Financial Officer | Sale | 4,000 | $70.00 | $280,000.00 | View Details |
| May 28, 2026 | Leproust Emily M. Director | Sale | 7,623 | $67.95 | $517,988.95 | View Details |
| May 28, 2026 | Leproust Emily M. Director | Sale | 1,482 | $65.33 | $96,812.54 | View Details |
| May 28, 2026 | Leproust Emily M. Director | Sale | 900 | $66.85 | $60,162.93 | View Details |
| May 28, 2026 | Leproust Emily M. Director | Sale | 6,465 | $68.61 | $443,590.16 | View Details |
| May 28, 2026 | Starovasnik Melissa A. Director | Sale | 2,500 | $68.00 | $170,000.00 | View Details |
| May 27, 2026 | Leproust Emily M. Director | Sale | 1,265 | $66.28 | $83,845.84 | View Details |
| May 27, 2026 | Leproust Emily M. Director | Sale | 23,752 | $65.24 | $1,549,561.48 | View Details |
107 more transactions available โ create a free account to see 12 months of history | ||||||
Showing 41โ48 of 48 transactions
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.